Home/Filings/4/0001104659-26-000272
4//SEC Filing

Taylor Andrew Lawrence 4

Accession 0001104659-26-000272

CIK 0001814114other

Filed

Jan 1, 7:00 PM ET

Accepted

Jan 2, 6:55 PM ET

Size

5.2 KB

Accession

0001104659-26-000272

Insider Transaction Report

Form 4
Period: 2026-01-02
Taylor Andrew Lawrence
Chief Financial Officer
Transactions
  • Tax Payment

    Common Stock, par value $0.0001 per share

    2026-01-02$4.31/sh3,452$14,878451,493 total
Footnotes (1)
  • [F1]Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units. No shares were sold in the market as a result of the vesting of these restricted stock units and the satisfaction of tax withholding obligations.

Issuer

Orchestra BioMed Holdings, Inc.

CIK 0001814114

Entity typeother

Related Parties

1
  • filerCIK 0001723889

Filing Metadata

Form type
4
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 6:55 PM ET
Size
5.2 KB